Vaccine Safety Surveillance during Outbrust of Covid-19 Pandemic: Regulatory Considerations

Abstract

Pharmacovigilance is a discipline of pharmacy that deals with tasks directly related to gathering, detecting, and keeping track of adverse medication reactions or occurrences seen in people or animals.

The covid-19 pandemic and the SARS-COV-2 outbreak led to the creation of an anti-covid-19 vaccine, which sparked a global competition. To combat the covid-19 and SARS-COV-2 outbreaks, numerous vaccinations have been developed and sold on the market. Covishield, BioNTech/Pfizer-m-RNA, Johnson & Johnson, Sputnik V, Moderna-m-RNA vaccination, Covaxin, etc. are anti-covid-19 vaccines. The pharmacovigilance of vaccines, used worldwide is reported in the current article.

Any unwelcome medical event that occurs after immunization but is not necessarily caused using the vaccine. According to "definition and application of terminologies for vaccine pharmacovigilance," AEFI is utilised. Vaccine safety surveillance is another name for AEFI surveillance. A surveillance system created to record unfavorable outcomes that are directly related to vaccination. This sort of surveillance often depends on medical practitioners identifying a negative event in a person as possibly being related to vaccination and reporting it to the NRA (National Regulatory Authorities) or other competent entity. In the current article, vaccination safety surveillance techniques were reported in addition to AEFI.